| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $407.9M | +74.7% |
| Cost of Revenue | $66.1M | +98.7% |
| Gross Profit | $341.7M | +70.8% |
| R&D Expense | $68.6M | +83.8% |
| SG&A Expense | $320.7M | +58.3% |
| Operating Income | -$47.6M | -19.4% |
| Interest Expense | $1.7M | -21.2% |
| Pre-tax Income | -$44.3M | -5.5% |
| Income Tax | $613K |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $441.6M | +105.9% |
| Short-term Investments | $9.8M | — |
| Accounts Receivable | $61.2M | +79.1% |
| Inventory | $11.9M | -31.0% |
| Current Assets | $530.0M | +97.4% |
| Total Assets | $564.9M | +91.4% |
| Current Liabilities | $61.2M | +48.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $11.6M | +157.5% |
| Capital Expenditures | $9.1M | +94.9% |
| Investing Cash Flow | -$19.6M | -167.3% |
| Financing Cash Flow | $235.1M | +1472.6% |
| Free Cash Flow | $2.5M | +110.0% |
| +751.4% |
| Net Income | -$44.9M | -6.8% |
| EPS (Basic) | -$1.60 | -3.9% |
| EPS (Diluted) | -$1.60 | -3.9% |
| Total Liabilities |
| $68.9M |
| +4.3% |
| Stockholders' Equity | $496.0M | +116.6% |